Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction.

Potter, S., Trickey, A., Rattay, T, O'Connell, R. L., Dave, R., Baker, E., Whisker, L., Skillman, J., Gardiner, M. D., Macmillan, R. D., Holcombe, C., Youssef, Mina and , Mammary Fold Academic and Research Collaborative (2020) Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction. British Journal of Surgery, 107 (7). pp. 832-844. ISSN 0007-1323

Full text not available from this repository. (Request a copy)

Abstract

Background: Therapeutic mammaplasty (TM) may be an alternative to mastectomy, but few well designed studies have evaluated the success of this approach or compared the short-term outcomes of TM with mastectomy with or without immediate breast reconstruction (IBR). Data from the national iBRA-2 and TeaM studies were combined to compare the safety and short-term outcomes of TM and mastectomy with or without IBR. Methods: The subgroup of patients in the TeaM study who underwent TM to avoid mastectomy were identified, and data on demographics, complications, oncology and adjuvant treatment were compared with those of patients undergoing mastectomy with or without IBR in the iBRA-2 study. The primary outcome was the percentage of successful breast-conserving procedures in the TM group. Secondary outcomes included postoperative complications and time to adjuvant therapy. Results: A total of 2916 patients (TM 376; mastectomy 1532; mastectomy and IBR 1008) were included in the analysis. Patients undergoing TM were more likely to be obese and to have undergone bilateral surgery than those having IBR. However, patients undergoing mastectomy with or without IBR were more likely to experience complications than the TM group (TM: 79, 21·0 per cent; mastectomy: 570, 37·2 per cent; mastectomy and IBR: 359, 35·6 per cent; P < 0·001). Breast conservation was possible in 87·0 per cent of patients who had TM, and TM did not delay adjuvant treatment. Conclusion: TM may allow high-risk patients who would not be candidates for IBR to avoid mastectomy safely. Further work is needed to explore the comparative patient-reported and cosmetic outcomes of the different approaches, and to establish long-term oncological safety.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 18 Sep 2020 00:30
Last Modified: 09 Oct 2020 23:58
URI: https://ueaeprints.uea.ac.uk/id/eprint/76923
DOI: 10.1002/bjs.11468

Actions (login required)

View Item View Item